EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Combined Letrozole and Growth Hormone Therapy in Late-Pubertal Males with Advanced Bone Age and Open Knee Physes

Hui Zhang, Pengxiang Zhou iD, Yunpu Cui, Xuemei Wang, Huiqiang Liu, Jinfang Yuan, Hua Zhang, Rongsheng Zhao, Tongyan Han, Xinli Wang

Children · 14.08.2026 · 13 (8) · 1077

DOI: 10.3390/children13081077 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Children, online erschienen am 14.08.2026. Verfasst von Hui Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Peking University Third Hospital, Beijing 100191, China. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Peking University Third Hospital, Beijing Integrative Medicine Association, National Institute of Hospital Administration, National Health Commission of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: The therapeutic window for growth hormone (GH) therapy in late-pubertal males with advanced bone age (BA ≥ 15 years) is generally considered closed. Yet, open knee physes may indicate residual growth potential. This single-arm retrospective study evaluated the efficacy and safety of letrozole combined with GH in Chinese males with short stature, advanced BA (15 –< 18 years), and open knee physes.

Methods

We included 139 male adolescents stratified by baseline BA: 15 ≤ BA < 16 (n = 24), 16 ≤ BA < 17 (n = 31), and 17 ≤ BA < 18 (n = 84). All received subcutaneous GH (0.05–0.07 mg/kg/day) and oral letrozole (2.5 mg/day). The primary outcome was the change in final adult height (FAH) from baseline predicted adult height (PAH). Longitudinal changes in height velocity and height SDS-BA were also assessed.

Results

Among 75 patients who reached FAH, combination therapy was associated with a mean gain of 6.58 ± 3.46 cm over baseline PAH (p < 0.001). The gain was inversely correlated with baseline BA; the largest gain occurred in the 15 ≤ BA < 16 subgroup (10.04 ± 4.66 cm), significantly exceeding gains in the 16 ≤ BA < 17 (6.30 ± 3.01 cm) and 17 ≤ BA < 18 (5.70 ± 2.52 cm) subgroups (p < 0.001). In the youngest subgroup, FAH exceeded mid-parental height. The safety profile was acceptable; acne was the most common adverse event (46.76%), and no severe metabolic or endocrine disorders were observed.

Conclusions

Letrozole plus GH therapy may be associated with improved FAH in late-pubertal males with advanced BA and open knee physes, with gains varying by baseline skeletal maturity and being numerically greatest in those with BA 15 –< 16 years. Knee epiphyseal status may be a useful consideration when individualizing therapy in this population.

Schlagwörter

Stichwörter der Autor:innen

bone agefinal adult heightgrowth hormoneletrozolereal-world study

Autor:innen und Institutionen

  • Department of Pediatrics, Peking University Third Hospital, Beijing 100191, China.
  • Department of Pharmacy, Peking University Third Hospital, Beijing 100191, China.
  • Institute for Drug Evaluation, Peking University Health Science Center, Beijing 100191, China.
  • Clinical Epidemiology Research Center, Peking University Third Hospital, Beijing 100191, China.

ORCID-Profile: Pengxiang Zhou

Förderung

  • Peking University Third Hospital
  • Beijing Integrative Medicine Association
  • National Institute of Hospital Administration, National Health Commission of China

Zitieren

APA

Zhang, H., Zhou, P., Cui, Y., Wang, X., Liu, H., Yuan, J., Zhang, H., Zhao, R., Han, T., & Wang, X. (2026). Combined Letrozole and Growth Hormone Therapy in Late-Pubertal Males with Advanced Bone Age and Open Knee Physes. Children, 13(8), 1077. https://doi.org/10.3390/children13081077

Vancouver

Zhang H, Zhou P, Cui Y, Wang X, Liu H, Yuan J, et al. Combined Letrozole and Growth Hormone Therapy in Late-Pubertal Males with Advanced Bone Age and Open Knee Physes. Children. 2026;13(8):1077. doi:10.3390/children13081077

BibTeX
@article{Zhang2026,
  author = {Zhang, Hui and Zhou, Pengxiang and Cui, Yunpu and Wang, Xuemei and Liu, Huiqiang and Yuan, Jinfang and Zhang, Hua and Zhao, Rongsheng and Han, Tongyan and Wang, Xinli},
  title = {Combined Letrozole and Growth Hormone Therapy in Late-Pubertal Males with Advanced Bone Age and Open Knee Physes},
  journal = {Children},
  year = {2026},
  volume = {13},
  number = {8},
  pages = {1077},
  doi = {10.3390/children13081077}
}
Kostenlos starten →